Common Contracts
4 similar Non-Qualified Stock Option Agreement contracts by Synta Pharmaceuticals Corp, Interleukin Genetics Inc
INTERLEUKIN GENETICS, INC.Non-Qualified Stock Option Agreement • November 18th, 2015 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
As of April 6, 2015 (the “Grant Date”), Interleukin Genetics, Inc. (the “Company”), a Delaware corporation, grants to Mark Carbeau (the “Participant”) the right and option (the “Option”) to purchase up to 11,622,279 shares of the common stock, $.001 par value per share, of the Company (the “Shares”) at a purchase price of $0.1525 per share (the “Purchase Price”) on the terms and conditions and subject to all the limitations set forth in this Agreement. For the purpose of this Agreement, the initial vesting date shall be April 6, 2016 (“Initial Vesting Date”).
NON-QUALIFIED STOCK OPTION AGREEMENT 225,000 SHARES OF COMMON STOCK,Non-Qualified Stock Option Agreement • March 12th, 2015 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
As of December 8, 2014 (the “Grant Date”), Synta Pharmaceuticals Corp. (the “Company”), a Delaware corporation, grants to Marc Schneebaum (the “Participant”) the right and option (the “Option”) to purchase up to 225,000 shares of the common stock, $.0001 par value per share, of the Company (the “Shares”) at a purchase price of $2.85 per share (the “Purchase Price”) on the terms and conditions and subject to all the limitations set forth in this Agreement. For the purpose of this Agreement, the initial vesting date shall be December 8, 2015 (“Initial Vesting Date”).
NON-QUALIFIED STOCK OPTION AGREEMENT 450,000 SHARES OF COMMON STOCK,Non-Qualified Stock Option Agreement • March 12th, 2015 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
As of December 8, 2014 (the “Grant Date”), Synta Pharmaceuticals Corp. (the “Company”), a Delaware corporation, grants to Chen Schor (the “Participant”) the right and option (the “Option”) to purchase up to 450,000 shares of the common stock, $.0001 par value per share, of the Company (the “Shares”) at a purchase price of $2.85 per share (the “Purchase Price”) on the terms and conditions and subject to all the limitations set forth in this Agreement. For the purpose of this Agreement, the initial vesting date shall be December 8, 2015 (“Initial Vesting Date”).
NON-QUALIFIED STOCK OPTION AGREEMENT 250,000 SHARES OF COMMON STOCK,Non-Qualified Stock Option Agreement • November 6th, 2014 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
As of September 2, 2014 (the “Grant Date”), Synta Pharmaceuticals Corp. (the “Company”), a Delaware corporation, grants to Anne C. Whitaker (the “Participant”) the right and option (the “Option”) to purchase up to 250,000 shares of the common stock, $.0001 par value per share, of the Company (the “Shares”) at a purchase price of $4.00 per share (the “Purchase Price”) on the terms and conditions and subject to all the limitations set forth in this Agreement. For the purpose of this Agreement, the initial vesting date shall be September 2, 2015 (“Initial Vesting Date”).
